Plain-English translation of ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When you have a severe COPD flare-up that lands you in the intensive care unit, doctors typically give you antibiotics right away — sometimes for longer than needed. This trial tests whether three types of information (a special genetic test that identifies what's causing the infection, a blood marker called procalcitonin, and how your sputum looks) can help your doctor decide exactly when it's safe to stop antibiotics. Half of participants will receive this personalized approach, while the other half will receive standard care where the doctor decides.
Taking antibiotics longer than necessary can harm you by killing beneficial bacteria and leading to resistant infections. This trial exists to see if using simple lab tests can safely shorten antibiotic treatment in critically ill COPD patients, helping them recover faster while reducing these risks.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to either the personalized strategy group or the standard care group. If assigned to the personalized group, a respiratory sample will be collected 12 hours after you enter the trial, and your care team will use the test results along with blood work and your sputum appearance to adjust your antibiotics daily through day 7. All participants will be followed until hospital discharge or day 28, with a final check-in at day 90 to see how you're doing.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
France